June 13, 2025

JAK Inhibitors Show No Increased Cancer Risk

New real-world data show no significant rise in overall cancer incidence with JAK inhibitors for rheumatoid arthritis patients, though skin cancer monitoring remains important.

Conexiant

June 01, 2025

Miami Cancer Institute Skin Cancer Conference, Second Annual

Live, In-Person Conference | 2.5 Cat. 1 - Wednesday, August 27, 2025: The Miami Cancer Institute Skin Cancer Conference is designed to highlight the significant multidisciplinary approach to surveillance and personalized treatment for skin cancer, promoting optimal outcomes as well as improved quality of life.

Baptist Health South Florida

May 21, 2025

Medical Oddities: Fingernail Selfies Spot Anemia

Tea, tech, TikTok & toxins: surprising health twists hiding in phones, roads, and skin care.

Conexiant

April 26, 2024

Vladimir Botchkarev, MD, PhD, Honored With 2023 Skin Ageing & Challenges Best Scientific Award

Vladimir Botchkarev received the 2023 Skin Ageing & Challenges Best Scientific Award.

Conexiant

March 10, 2025

Baricitinib Effective for Teen Alopecia

Eli Lilly's JAK inhibitor demonstrated 80% scalp hair regrowth in 42.4% of adolescents with severe alopecia areata after just 36 weeks of treatment, outperforming placebo in the Phase 3 BRAVE-AA-PEDS trial.

Conexiant

December 30, 2024

Nutrafol Safety Signal Emerges in Case Study

A previously healthy 26-year-old developed severe liver injury after using Nutrafol, with a biopsy confirming marked necroinflammatory damage with complete resolution upon discontinuation.

Conexiant

May 21, 2024

Onychopapilloma May Be Linked to BAP1 Tumor Predisposition Syndrome

Researchers have discovered that the presence of a benign nail condition known as onychopapilloma may lead to the diagnosis of BAP1 tumor predisposition syndrome.

Conexiant

April 29, 2024

New Strategies to Manage and Minimize Exposure to HIV, Other STIs; Advance Gender-Affirming Care

New treatments for HIV and STIs in LGBTQ+ patients, including novel preventive measures and dermatological care for transgender and gender-diverse patients, are highlighted in a recent AAD press release.

Conexiant

April 30, 2024

AAD 2024: AAD Welcomes Seemal R. Desai, MD, FAAD, as President

Seemal R. Desai, MD, FAAD, began his 1-year term as President of the American Academy of Dermatology (AAD) as well as its sister association the AAD Association at the conclusion of the 2024 AAD Annual Meeting.

Conexiant